Cargando…

Characterization of monoclonal antibody's binding kinetics using oblique-incidence reflectivity difference approach

Monoclonal antibodies (mAbs) against human proteins are the primary protein capture reagents for basic research, diagnosis, and molecular therapeutics. The 2 most important attributes of mAbs used in all of these applications are their specificity and avidity. While specificity of a mAb raised again...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Shuang, Zhang, Hongyan, Dai, Jun, Hu, Shaohu, Pino, Ignacio, Eichinger, Daniel J, Lyu, Huibin, Zhu, Heng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4622085/
https://www.ncbi.nlm.nih.gov/pubmed/25530170
http://dx.doi.org/10.4161/19420862.2014.985919
_version_ 1782397540987043840
author Liu, Shuang
Zhang, Hongyan
Dai, Jun
Hu, Shaohu
Pino, Ignacio
Eichinger, Daniel J
Lyu, Huibin
Zhu, Heng
author_facet Liu, Shuang
Zhang, Hongyan
Dai, Jun
Hu, Shaohu
Pino, Ignacio
Eichinger, Daniel J
Lyu, Huibin
Zhu, Heng
author_sort Liu, Shuang
collection PubMed
description Monoclonal antibodies (mAbs) against human proteins are the primary protein capture reagents for basic research, diagnosis, and molecular therapeutics. The 2 most important attributes of mAbs used in all of these applications are their specificity and avidity. While specificity of a mAb raised against a human protein can be readily defined based on its binding profile on a human proteome microarray, it has been a challenge to determine avidity values for mAbs in a high-throughput and cost-effective fashion. To undertake this challenge, we employed the oblique-incidence reflectivity difference (OIRD) platform to characterize mAbs in a protein microarray format. We first systematically determined the K(on) and K(off) values of 50 mAbs measured with the OIRD method and deduced the avidity values. Second, we established a multiplexed approach that simultaneously measured avidity values of a mixture of 9 mono-specific mAbs that do not cross-react to the antigens. Third, we demonstrated that avidity values of a group of mAbs could be sequentially determined using a flow-cell device. Finally, we implemented a sequential competition assay that allowed us to bin multiple mAbs that recognize the same antigens. Our study demonstrated that OIRD offers a high-throughput and cost-effective platform for characterization of the binding kinetics of mAbs.
format Online
Article
Text
id pubmed-4622085
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-46220852015-12-21 Characterization of monoclonal antibody's binding kinetics using oblique-incidence reflectivity difference approach Liu, Shuang Zhang, Hongyan Dai, Jun Hu, Shaohu Pino, Ignacio Eichinger, Daniel J Lyu, Huibin Zhu, Heng MAbs Reports Monoclonal antibodies (mAbs) against human proteins are the primary protein capture reagents for basic research, diagnosis, and molecular therapeutics. The 2 most important attributes of mAbs used in all of these applications are their specificity and avidity. While specificity of a mAb raised against a human protein can be readily defined based on its binding profile on a human proteome microarray, it has been a challenge to determine avidity values for mAbs in a high-throughput and cost-effective fashion. To undertake this challenge, we employed the oblique-incidence reflectivity difference (OIRD) platform to characterize mAbs in a protein microarray format. We first systematically determined the K(on) and K(off) values of 50 mAbs measured with the OIRD method and deduced the avidity values. Second, we established a multiplexed approach that simultaneously measured avidity values of a mixture of 9 mono-specific mAbs that do not cross-react to the antigens. Third, we demonstrated that avidity values of a group of mAbs could be sequentially determined using a flow-cell device. Finally, we implemented a sequential competition assay that allowed us to bin multiple mAbs that recognize the same antigens. Our study demonstrated that OIRD offers a high-throughput and cost-effective platform for characterization of the binding kinetics of mAbs. Taylor & Francis 2014-12-21 /pmc/articles/PMC4622085/ /pubmed/25530170 http://dx.doi.org/10.4161/19420862.2014.985919 Text en © 2015 The Author(s). Published with license by Taylor & Francis Group, LLC http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. The moral rights of the named author(s) have been asserted.
spellingShingle Reports
Liu, Shuang
Zhang, Hongyan
Dai, Jun
Hu, Shaohu
Pino, Ignacio
Eichinger, Daniel J
Lyu, Huibin
Zhu, Heng
Characterization of monoclonal antibody's binding kinetics using oblique-incidence reflectivity difference approach
title Characterization of monoclonal antibody's binding kinetics using oblique-incidence reflectivity difference approach
title_full Characterization of monoclonal antibody's binding kinetics using oblique-incidence reflectivity difference approach
title_fullStr Characterization of monoclonal antibody's binding kinetics using oblique-incidence reflectivity difference approach
title_full_unstemmed Characterization of monoclonal antibody's binding kinetics using oblique-incidence reflectivity difference approach
title_short Characterization of monoclonal antibody's binding kinetics using oblique-incidence reflectivity difference approach
title_sort characterization of monoclonal antibody's binding kinetics using oblique-incidence reflectivity difference approach
topic Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4622085/
https://www.ncbi.nlm.nih.gov/pubmed/25530170
http://dx.doi.org/10.4161/19420862.2014.985919
work_keys_str_mv AT liushuang characterizationofmonoclonalantibodysbindingkineticsusingobliqueincidencereflectivitydifferenceapproach
AT zhanghongyan characterizationofmonoclonalantibodysbindingkineticsusingobliqueincidencereflectivitydifferenceapproach
AT daijun characterizationofmonoclonalantibodysbindingkineticsusingobliqueincidencereflectivitydifferenceapproach
AT hushaohu characterizationofmonoclonalantibodysbindingkineticsusingobliqueincidencereflectivitydifferenceapproach
AT pinoignacio characterizationofmonoclonalantibodysbindingkineticsusingobliqueincidencereflectivitydifferenceapproach
AT eichingerdanielj characterizationofmonoclonalantibodysbindingkineticsusingobliqueincidencereflectivitydifferenceapproach
AT lyuhuibin characterizationofmonoclonalantibodysbindingkineticsusingobliqueincidencereflectivitydifferenceapproach
AT zhuheng characterizationofmonoclonalantibodysbindingkineticsusingobliqueincidencereflectivitydifferenceapproach